Research ArticleHuman Studies
In Vivo Fate of Monoclonal Antibody B72.3 in Patients with Colorectal Cancer
David Colcher, Diane E. Milenic, Patrizia Ferroni, Jorge A. Carrasquillo, James C. Reynolds, Mario Roselli, Steven M. Larson and Jeffrey Schlom
Journal of Nuclear Medicine July 1990, 31 (7) 1133-1142;
David Colcher
Diane E. Milenic
Patrizia Ferroni
Jorge A. Carrasquillo
James C. Reynolds
Mario Roselli
Steven M. Larson
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
In Vivo Fate of Monoclonal Antibody B72.3 in Patients with Colorectal Cancer
David Colcher, Diane E. Milenic, Patrizia Ferroni, Jorge A. Carrasquillo, James C. Reynolds, Mario Roselli, Steven M. Larson, Jeffrey Schlom
Journal of Nuclear Medicine Jul 1990, 31 (7) 1133-1142;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Construction, Affinity Maturation, and Biological Characterization of an Anti-tumor-associated Glycoprotein-72 Humanized Antibody
- Characterization of Human IgG Antimouse Antibody in Patients with B-Cell Malignancies
- Grafting of "Abbreviated" Complementarity-Determining Regions Containing Specificity-Determining Residues Essential for Ligand Contact to Engineer a Less Immunogenic Humanized Monoclonal Antibody
- Structural Correlates of an Anticarcinoma Antibody: Identification of Specificity-Determining Residues (SDRs) and Development of a Minimally Immunogenic Antibody Variant by Retention of SDRs Only